Rochereau N - Search Results

1

Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity.

Pavot V, Rochereau N, Rességuier J, Gutjahr A, Genin C, Tiraby G, Perouzel E, Lioux T, Vernejoul F, Verrier B, Paul S. Pavot V, et al. Among authors: rochereau n. J Immunol. 2014 Dec 15;193(12):5781-5. doi: 10.4049/jimmunol.1402184. Epub 2014 Nov 12. J Immunol. 2014. PMID: 25392526

2

Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells.

Primard C, Rochereau N, Luciani E, Genin C, Delair T, Paul S, Verrier B. Primard C, et al. Among authors: rochereau n. Biomaterials. 2010 Aug;31(23):6060-8. doi: 10.1016/j.biomaterials.2010.04.021. Epub 2010 May 14. Biomaterials. 2010. PMID: 20471085

3

Phenotypic localization of distinct DC subsets in mouse Peyer Patch.

Rochereau N, Verrier B, Pin JJ, Genin C, Paul S. Rochereau N, et al. Vaccine. 2011 May 9;29(20):3655-61. doi: 10.1016/j.vaccine.2011.03.012. Epub 2011 Mar 23. Vaccine. 2011. PMID: 21439318

4

New insights in mucosal vaccine development.

Pavot V, Rochereau N, Genin C, Verrier B, Paul S. Pavot V, et al. Among authors: rochereau n. Vaccine. 2012 Jan 5;30(2):142-54. doi: 10.1016/j.vaccine.2011.11.003. Epub 2011 Nov 12. Vaccine. 2012. PMID: 22085556 Review.

5

Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties.

Pavot V, Rochereau N, Primard C, Genin C, Perouzel E, Lioux T, Paul S, Verrier B. Pavot V, et al. Among authors: rochereau n. J Control Release. 2013 Apr 10;167(1):60-7. doi: 10.1016/j.jconrel.2013.01.015. Epub 2013 Jan 23. J Control Release. 2013. PMID: 23352911

6

Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.

Benjelloun F, Dawood R, Urcuqui-Inchima S, Rochereau N, Chanut B, Verrier B, Lucht F, Genin C, Paul S. Benjelloun F, et al. Among authors: rochereau n. AIDS. 2013 Jul 31;27(12):1992-5. doi: 10.1097/QAD.0b013e3283632ea1. AIDS. 2013. PMID: 23696073

7

Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.

Rochereau N, Drocourt D, Perouzel E, Pavot V, Redelinghuys P, Brown GD, Tiraby G, Roblin X, Verrier B, Genin C, Corthésy B, Paul S. Rochereau N, et al. PLoS Biol. 2013 Sep;11(9):e1001658. doi: 10.1371/journal.pbio.1001658. Epub 2013 Sep 17. PLoS Biol. 2013. PMID: 24068891 Free PMC article.

8

Recent progress in HIV vaccines inducing mucosal immune responses.

Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S. Pavot V, et al. Among authors: rochereau n. AIDS. 2014 Jul 31;28(12):1701-18. doi: 10.1097/QAD.0000000000000308. AIDS. 2014. PMID: 25009956 Review.

9

Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells.

Rochereau N, Pavot V, Verrier B, Ensinas A, Genin C, Corthésy B, Paul S. Rochereau N, et al. Eur J Immunol. 2015 Mar;45(3):773-9. doi: 10.1002/eji.201444816. Epub 2015 Jan 14. Eur J Immunol. 2015. PMID: 25412898 Free article.

10

Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.

Rochereau N, Pavot V, Verrier B, Jospin F, Ensinas A, Genin C, Corthésy B, Paul S. Rochereau N, et al. J Allergy Clin Immunol. 2016 Jan;137(1):214-222.e2. doi: 10.1016/j.jaci.2015.07.042. Epub 2015 Sep 26. J Allergy Clin Immunol. 2016. PMID: 26414879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters